Methods of Treating Cancer Using PD1 or PD-L1 (a.k.a. B7-H1) Antibodies

Technology #2004-239

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Categories
Researchers
Eugene D. Kwon M.D.
Scott E. Strome M.D.
Lieping Chen M.D., Ph.D.
Managed By
Leif R. Nelson
Patent Protection
US Patent Pending
US Patent Pending
US Patent Pending
US Patent Pending
US Patent Pending
US Patent Pending
US Patent Pending

Mayo Clinic has patent rights claiming the use of PD1 and PD-L1 antibodies to treat cancer. The patent rights also include diagnostic and prognostic claims.